Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZTC -- Ignore unavailable to you. Want to Upgrade?

To: Sleepman who wrote (511)	2/5/1998 1:17:00 PM
From: H. Bradley Toland, Jr.	Read Replies (1) \| Respond to of 752

Dr Dan, GZTC does have cash problems, but not the kind your thinking of. It has so many requests from other companies to partner in interesting projects that it simply doesn't have the resources to move on all of them. What a problem! As for the demise of GZTC by year end, forget it. Their prospects are so good that they will easily be able to sell a million or two shares. By the way, they are closer to break even, now, because of existing business than your sales guy suggests. Brokers are sales guys. Do yourself a favor and don't ask them for advise. Just use them to simply broker your transactions. That's their function. I also think NXCO is an interesting company. And I'll also include Genzyme GENZ, and Geltex GELX. P.S.--Ligand has good potential too. Perhaps in the long term, however, GZTC has more potential, so you might want to a shift a little of your resources into GZTC. Good luck.